AARD vs. SCHD
AARD (Aardvark Therapeutics, Inc) is a stock, while SCHD (Schwab U.S. Dividend Equity ETF) is Dividend fund tracking the Dow Jones U.S. Dividend 100 Index. Over the past year, AARD returned -65.44% vs 26.07% for SCHD. At a 0.20 correlation, their price movements are largely independent.
Performance
AARD vs. SCHD - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, AARD achieves a -63.50% return, which is significantly lower than SCHD's 18.92% return.
AARD
- 1D
- -5.34%
- 1M
- 20.05%
- YTD
- -63.50%
- 6M
- -64.91%
- 1Y
- -65.44%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
SCHD
- 1D
- 0.41%
- 1M
- -0.63%
- YTD
- 18.92%
- 6M
- 18.01%
- 1Y
- 26.07%
- 3Y*
- 14.47%
- 5Y*
- 8.79%
- 10Y*
- 12.84%
AARD vs. SCHD - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
AARD Aardvark Therapeutics, Inc | -63.50% | -13.54% |
SCHD Schwab U.S. Dividend Equity ETF | 18.92% | 3.10% |
Correlation
The correlation between AARD and SCHD is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.19 |
Correlation (All Time) Calculated using the full available price history since Feb 13, 2025 | 0.20 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AARD vs. SCHD — Risk / Return Rank
AARD
SCHD
AARD vs. SCHD - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Aardvark Therapeutics, Inc (AARD) and Schwab U.S. Dividend Equity ETF (SCHD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| AARD | SCHD | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.98 | ||
| Sortino ratioReturn per unit of downside risk | -4.06 | ||
| Omega ratioGain probability vs. loss probability | 0.94 | 1.43 | -0.49 |
| Calmar ratioReturn relative to maximum drawdown | -0.82 | 5.67 | -6.49 |
| Martin ratioReturn relative to average drawdown | -1.38 | 13.65 | -15.03 |
Loading charts...
Drawdowns
AARD vs. SCHD - Drawdown Comparison
The maximum AARD drawdown since its inception was -80.01%, which is greater than SCHD's maximum drawdown of -33.37%. Use the drawdown chart below to compare losses from any high point for AARD and SCHD.
Loading charts...
Drawdown Indicators
| AARD | SCHD | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -80.01% | -33.37% | -46.64% |
Max Drawdown (1Y)Largest decline over 1 year | -80.01% | -4.61% | -75.40% |
Max Drawdown (3Y)Largest decline over 3 years | — | -16.13% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -16.85% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.37% | — |
Current DrawdownCurrent decline from peak | -72.49% | -1.48% | -71.01% |
Average DrawdownAverage peak-to-trough decline | -42.16% | -3.31% | -38.85% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 47.42% | 1.92% | +45.50% |
Volatility
AARD vs. SCHD - Volatility Comparison
Aardvark Therapeutics, Inc (AARD) has a higher volatility of 23.44% compared to Schwab U.S. Dividend Equity ETF (SCHD) at 3.14%. This indicates that AARD's price experiences larger fluctuations and is considered to be riskier than SCHD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| AARD | SCHD | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 23.44% | 3.14% | +20.30% |
Volatility (6M)Calculated over the trailing 6-month period | 107.55% | 7.73% | +99.82% |
Volatility (1Y)Calculated over the trailing 1-year period | 108.75% | 11.04% | +97.71% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 113.65% | 14.35% | +99.30% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 113.65% | 16.70% | +96.95% |
Dividends
AARD vs. SCHD - Dividend Comparison
AARD has not paid dividends to shareholders, while SCHD's dividend yield for the trailing twelve months is around 3.27%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AARD Aardvark Therapeutics, Inc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SCHD Schwab U.S. Dividend Equity ETF | 3.27% | 3.82% | 3.64% | 3.49% | 3.39% | 2.78% | 3.16% | 2.98% | 3.06% | 2.63% | 2.89% | 2.97% |
Frequently Asked Questions
AARD and SCHD have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AARD has higher volatility (23.44%) compared to SCHD (3.14%). In terms of maximum drawdown, AARD dropped -80.01% vs SCHD's -33.37%.
SCHD currently has the higher Sharpe Ratio (2.38 vs -0.61), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for AARD and SCHD
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer